Literature DB >> 4886920

Immunosuppressive effects of cytosine arabinoside and methotrexate in man.

M S Mitchell, M E Wade, R C DeConti, J R Bertino, P Calabresi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4886920     DOI： 10.7326/0003-4819-70-3-535

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  17 in total

Review 1.  Current management of polymyositis and dermatomyositis.

Authors:  C V Oddis; T A Medsger
Journal:  Drugs       Date:  1989-03       Impact factor: 9.546

2.  Methotrexate therapy in rheumatoid arthritis. Current status.

Authors:  W S Wilke; A H Mackenzie
Journal:  Drugs       Date:  1986-08       Impact factor: 9.546

3.  Effect of azathioprine and cytosine arabinoside on humoral and cellular immunity in vitro.

Authors:  M Röllinghoff; J Schrader; H Wagner
Journal:  Clin Exp Immunol       Date:  1973-10       Impact factor: 4.330

4.  In vitro studies of the cell-bound and antibody-mediated immunity evoked by murine renal allotransplants. Influence of presensitization, total body irradiation and immunosuppressive agents.

Authors:  B S Husberg
Journal:  Clin Exp Immunol       Date:  1973-06       Impact factor: 4.330

5.  Methotrexate therapy in polymyositis.

Authors:  F C Arnett; J C Whelton; T M Zizic; M B Stevens
Journal:  Ann Rheum Dis       Date:  1973-11       Impact factor: 19.103

6.  A comparative study of the action of cyclophosphamide and procarbazine on the antibody production in mice.

Authors:  R Liske
Journal:  Clin Exp Immunol       Date:  1973-10       Impact factor: 4.330

7.  Effect of chemotherapy and immunotherapy on tumor-specific immunity in melanoma.

Authors:  M S Mitchell; M B Mokyr; J M Davis
Journal:  J Clin Invest       Date:  1977-06       Impact factor: 14.808

8.  Methotrexate for steroid-resistant systemic lupus erythematosus.

Authors:  M Hashimoto; S Nonaka; E Furuta; T Wada; Y Suenaga; M Yasuda; M Shingu; M Nobunaga
Journal:  Clin Rheumatol       Date:  1994-06       Impact factor: 2.980

9.  The treatment of disseminated vasculitis with methotrexate.

Authors:  M S Mitchell; R H Gifford; J R Bertino; J D Kenney; S E Malawista
Journal:  Inflammation       Date:  1976-06       Impact factor: 4.092

10.  Immune function in multiple myeloma: impaired responsiveness to keyhole limpet hemocyanin.

Authors:  J Harris; R Alexanian; E Hersh; P Migliore
Journal:  Can Med Assoc J       Date:  1971-03-06       Impact factor: 8.262
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.